Key facts
- Hanwha Impact is a other based in Seoul, Jung-gu with 6 tracked portfolio companies.
- Notable positions include Inari, Tessera Therapeutics, Cellarity, Ensoma, Neutron Holdings.
About Hanwha Impact
Hanwha Impact is a corporation based in Seoul, South Korea. Established in 1974, the firm seeks to invest in the energy, biotechnology, mobility, technology convergence, and aerospace sectors. The assets of the firm are managed by the executive management team.
Free account
See the whole book
- ·Watchlist + alerts for Hanwha Impact's activity
Create free account
No card required
Portfolio, priced
6 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Inari | — | $2.2B | — | |
| Tessera Therapeutics | — | $650.0M | — | |
| Cellarity | — | $525.0M | — | |
| Ensoma | Drug Discovery | $280.0M | — | |
| Neutron Holdings | — | — | — | |
| Catalog (Biotechnology) | — | — | — |
Frequently asked
- What companies does Hanwha Impact invest in?
- Hanwha Impact has 6 recorded portfolio companies, including Inari, Tessera Therapeutics, Cellarity, Ensoma.